3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Anemia
2
Pancreatic Neoplasms
1
Interventions
Gemcitabine
3
Pancreaticoduodenectomy
2
Oxaliplatin
2
Erlotinib Hydrochloride
2
olaparib
1
irinotecan sucrosofate
1
ferric carboxymaltose
1
binimetinib
1
Taxes
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiofrequency Ablation
1
Radiation
1
Propranolol
1
Positron Emission Tomography Computed Tomography
1
Pancreatectomy
1
Nivolumab
1
Mitomycin
1
Leucovorin
1
Ipilimumab
1
Immobilization
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fluorouracil
1
Etodolac
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Drainage
1
Curcumin
1
Congresses as Topic
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Pancreatic Neoplasms
×
ferric carboxymaltose
×
Clear all
NCT02628860
2020-04-28
FCM
National Cancer Center, Korea
Phase 2
Completed
40 enrolled